DOI:
10.1055/s-00000058
Planta Medica
LinksClose Window
References
Trigo J, Subbiah V, Besse B, Moreno V, López R, Sala MA, Peters S, Ponce S, Fernández C, Alfaro V, Gómez J, Kahatt C, Zeaiter A, Zaman K, Boni V, Arrondeau J, Martínez M, Delord JP, Awada A, Kristeleit R, Olmedo ME, Wannesson L, Valdivia J, Rubio MJ, Anton A, Sarantopoulos J, Chawla SP, Mosquera-Martinez J, DʼArcangelo M, Santoro A, Villalobos VM, Sands J, Paz-Ares L.
Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial.
Lancet Oncol 2020;
21: 645-654
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.